Kynam Capital Management, LP
- SEC CIK
- 0001907884
- Latest filing
- Aug 14, 2026
GYRE holding history
Gyre Therapeutics, Inc. in every 13F filed by Kynam Capital Management, LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GYRE overviewAll 13F holders of GYREFull Q2 2026 holdings
- Shares (Q4 2023)
- 0
- Sold out in Q4 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 8
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2023 | 0 | $0 | 0.0% | −90,058−100.0% | Sold out | Holders |
| Q3 2023 | 90,058 | $43.4K | <0.1% | +172+0.2% | Added | Holders |
| Q2 2023 | 89,886 | $31.6K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 89,886 | $18.6K | <0.1% | −598−0.7% | Reduced | Holders |
| Q4 2022 | 90,484 | $47.7K | <0.1% | +296+0.3% | Added | Holders |
| Q3 2022 | 90,188 | $45.0K | <0.1% | −3,246−3.5% | Reduced | Holders |
| Q2 2022 | 93,434 | $166.0K | <0.1% | −12,655−11.9% | Reduced | Holders |
| Q1 2022 | 106,089 | $70.0K | <0.1% | −4,902−4.4% | Reduced | Holders |
| Q4 2021 | 110,991 | $101.0K | 0.1% | – | No prior filing | Holders |